Wegovy's list price without insurance runs $1,300-$1,350/month. That number is accurate but misleading — because it's not your only option. Here's the complete picture on Wegovy pricing and the legal alternative that costs 85% less.
Wegovy (semaglutide) without insurance costs $1,300-$1,350 per month at list price. That number is the reason most people searching "Wegovy without insurance" immediately assume the medication is financially out of reach — but that conclusion is based on incomplete information.
Wegovy is Novo Nordisk's brand-name, FDA-approved formulation of semaglutide specifically for chronic weight management. The price reflects brand manufacturing, the injector pen delivery device, marketing costs, and the absence of generic competition (semaglutide's patent protections are still active).
Without insurance coverage — and most insurance plans either exclude weight-loss medications entirely or impose strict prior authorization requirements — patients are quoted the full list price.
| Option | Monthly cost | What you get |
|---|---|---|
| Wegovy at list price | $1,300-$1,350 | Brand pen, full insurance-free price |
| NovoCare cash savings program | $499 | Brand Wegovy, if you qualify (no insurance, certain conditions) |
| Compounded semaglutide | $99-199 | Same active molecule, licensed compounding pharmacy, physician-prescribed |
Novo Nordisk's NovoCare savings program offers Wegovy at $499/month cash price for eligible patients without insurance coverage for the medication. Eligibility typically requires: a valid prescription, US residency, no government insurance (Medicare/Medicaid) covering the medication, and enrollment through the NovoCare website directly. This is real brand-name Wegovy at a meaningfully reduced price — worth checking directly at NovoCare.com if you specifically want the brand product.
Compounded semaglutide contains the identical active molecule as Wegovy — semaglutide is semaglutide regardless of manufacturer. The difference is the source: a licensed compounding pharmacy prepares it based on an individual physician prescription, rather than Novo Nordisk's mass manufacturing and pre-filled pen device.
At $99-199/month depending on dose, compounded semaglutide costs roughly 85-90% less than Wegovy's list price, while delivering the same GLP-1 receptor activation and the same clinical effect at equivalent doses.
DirectMeds offers physician-supervised compounded semaglutide from $99/month — the same active molecule as Wegovy, without the brand markup. Free eligibility check, no insurance required.
Check eligibility at DirectMeds →